Home Genetics / Genomics Cell Surface Receptor Identification Using Genome-Scale CRISPR/Cas9 Genetic Screens
Genetics / Genomics JoVE (Open Access) Citable · DOI

Cell Surface Receptor Identification Using Genome-Scale CRISPR/Cas9 Genetic Screens

· 2020
DOI: 10.3791/60803
What you'll learn
  • Design and execute genome-scale CRISPR/Cas9 screens to identify cell surface receptors
  • Quantify biotinylated protein oligomerization for screening applications
  • Analyze genetic screening data using bioinformatics to map receptor-ligand interactions
Protocol

This manuscript describes a genome-scale cell-based screening approach to identify extracellular receptor-ligand interactions.

Difficulty
advanced
Total time
~3–4 weeks (including cell line generation, screening, and bioinformatics analysis)
Model organism
Mammalian cell lines (HEK293 or similar)
Biosafety
BSL-1

Steps

1
Introduce genome-scale CRISPR screening for receptor identification

Overview of the cell-based screening approach and rationale for identifying extracellular receptor-ligand interactions using CRISPR/Cas9 technology.

▶ 00:04
2
Quantify and oligomerize biotinylated protein monomers

Prepare and characterize monomeric biotinylated proteins, including quantification and oligomerization steps to generate multivalent ligand baits for screening.

▶ 01:07
3
Perform genetic screening for cell surface binding

Execute genome-scale CRISPR/Cas9 screening in cell populations to identify genes whose knockout eliminates or enhances binding of the biotinylated ligand.

▶ 03:26
4
Conduct bioinformatics analysis on screening results

Analyze sequencing data from genetic screens using computational methods to identify candidate receptors and annotate related signaling pathways.

▶ 05:13
5
Interpret genetic screening results and receptor identification

Review validated hits from genome-scale screening, highlighting cell surface binding partners identified and their functional relevance.

▶ 06:05
6
Summarize applications and future directions

Conclude with key takeaways on using CRISPR screens for unbiased receptor discovery and potential downstream validation strategies.

▶ 07:57
💬 Comments coming soon